We supply the Intermediates:
5-Nitro-2-Thiophenic Acid
3,4-Dihydro-2,6-Dimethyl-4-Oxo Quinazoline
6-(Bromomethyl)-3,4-Dihydro-2-Methyl-4-Oxo Quinazoline
Diethyl-N-(5-Methylamino-2-Thenoyl)-L-Glutamate
Diethyl,N-[[5-(3,4-Dihydro-2-Methyl-4-Oxo-6-Quinazolinyl)-Methyl]-N-Methyl]-2-Thienylcarbonyl-L-Glutamate



CAS:112887-68-0
MF:C₂₁H₂₂N₄O₆S
MW:458.5

Indication:
The first line of advanced colorectal cancer treatment.